Drug profile

The FDA adverse-event record for Fluid Therapy (Unknown)

383 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Fluid Therapy (Unknown). See the species affected, top reactions, and outcomes below.

383
adverse-event reports
21.7%
death-coded share
Cat
most-reported species
77
Not eating - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
383
Total Reports
83
Deaths Reported
21.7%
Death Rate

Active Ingredients

Fluid Therapy (Unknown)

Administration Routes

UnknownSubcutaneousIntravenousParenteralOther

Species Affected

Cat 222
Dog 161

Most Affected Breeds

Domestic Shorthair 123
Retriever - Labrador 28
Cat (unknown) 27
Domestic Longhair 25
Domestic Mediumhair 15
Pit Bull 10
Maine Coon 6
Maltese 6
Poodle - Miniature 6
Siamese 5

Most Reported Reactions

Not eating 77
Vomiting 70
Death by euthanasia 61
Behavioural disorder NOS 58
Lethargy (see also Central nervous system depression in Neurological) 58
Other abnormal test result NOS 53
Dehydration 45
Weight loss 41
Diarrhoea 39
Elevated blood urea nitrogen (BUN) 38
Lethargy (see also Central nervous system depression in 'Neurological') 34
Anorexia 32

Outcome Breakdown

Ongoing
132 (34.4%)
Outcome Unknown
101 (26.3%)
Recovered/Normal
66 (17.2%)
Euthanized
60 (15.6%)
Died
23 (6.0%)
Recovered with Sequela
2 (0.5%)

Fluid Therapy (Unknown) Adverse Event Insights

383 reports name Fluid Therapy (Unknown); 83 recorded a death outcome (21.7% of reported events, not a population-level mortality rate). Active ingredient: Fluid Therapy (Unknown). Administration routes: Unknown, Subcutaneous, Intravenous, Parenteral.

By species: Cat (222 reports), Dog (161 reports). By breed: Domestic Shorthair (123), Retriever - Labrador (28), Cat (unknown) (27).

Leading clinical signs: Not eating (77), Vomiting (70), Death by euthanasia (61), Behavioural disorder NOS (58). Outcome, 384 coded reports: Ongoing leads at 34.4%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.